Codiak Biosciences
The leader in the emerging field of exosome therapeutics, working to harness the power of this cellular messenger system to create potentially life-changing medicines.
Launch date
Employees
Market cap
AUD1.4m
Enterprise valuation
AUD16m (Public information from Apr 2023)
Share price
$0.057 CDAK
San Francisco California (HQ)
Authorizing premium user...